Literature DB >> 2247918

Retrograde transurethral balloon dilation of prostate: innovative management of abacterial chronic prostatitis and prostatodynia.

W B Lopatin1, M Martynik, D P Hickey, C Vivas, T R Hakala.   

Abstract

Retrograde transurethral balloon dilatation (RTBD) of the prostate recently has been suggested as alternative therapy for patients with benign prostatic hyperplasia (BPH). Seven patients with documented functional urinary outlet obstruction at the level of the bladder neck or prostatic urethra underwent RTBD of prostate. Each patient had a classic diagnosis of abacterial chronic prostatitis or prostatodynia based on history, physical examination, and localization cultures. Prior to RTBD of prostate, patients underwent cystoscopy, voiding cystourethrogram, urodynamic and uroflow studies. RTBD of prostate was done as an outpatient procedure requiring intravenous sedation or general anesthesia. Dilation was performed with a 25-mm urethroplasty balloon catheter inflated at 3.5 atm of pressure for twenty minutes. Improvement in voiding symptomatology was noted in all patients and graded numerically (0-10 scale), with ten indicating normal voiding. Follow-up to date ranges from one to five months. This technique may have promise as a treatment option in patients with abacterial chronic prostatitis and prostatodynia.

Entities:  

Mesh:

Year:  1990        PMID: 2247918     DOI: 10.1016/0090-4295(90)80188-s

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

Review 1.  Interventional radiology of the lower urinary tract and its relationship to surgical treatment.

Authors:  F Castañeda; J M Hernández-Graulau; W R Castañeda-Zúñiga
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jul-Aug       Impact factor: 2.740

2.  Advancements in the management of urologic chronic pelvic pain: what is new and what do we know?

Authors:  Justin Parker; Sorin Buga; Jose E Sarria; Philippe E Spiess
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 3.  Minimally invasive therapies for prostatitis.

Authors:  Peter Zvara; Jeffrey B Folsom; Mark K Plante
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

Review 4.  Advanced therapy for prostatitis: minimally invasive and invasive therapies.

Authors:  Assaad El-Hakim; Darshan K Shah; Arthur D Smith
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 5.  The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer.

Authors:  Tongwen Ou; Michael Lilly; Wei Jiang
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

6.  Increased Preoperative Plasma Level of Microbial 16S rDNA Translocation Is Associated With Relapse After Prostatectomy in Prostate Cancer Patients.

Authors:  Tongwen Ou; Zejun Zhou; David P Turner; Baoli Zhu; Michael Lilly; Wei Jiang
Journal:  Front Oncol       Date:  2020-01-15       Impact factor: 6.244

7.  Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals.

Authors:  Xu Wang; Zejun Zhou; David Turner; Michael Lilly; Tongwen Ou; Wei Jiang
Journal:  J Immunol Res       Date:  2022-02-03       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.